Article
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
2020-10-07
Abstract excerpt
There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing aggressive from indolent disease, particularly in patients with localised intermediate grade prostate cancer. There ha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e74c81d4-035c-58b9-aebd-f22a06960569
- DOI
- 10.20944/preprints202010.0154.v1